Testosterone Replacement Therapy Market by application, Outlook and forecast 2019-2027 – Crypto Journal

Posted on by

The Testosterone Replacement Therapy Market Report is a valuable source of information for corporate strategists. This study contains comprehensive data that enhances the understanding, scope and application of this report. The report contains all the necessary information about the latest innovations, such as: For example, Porters five-pot model analysis and advanced profiles of elite industry participants.

The major players in the Testosterone Replacement Therapy Market investigated in this report are: AbbVie, Inc., Bayer AG, Endo Pharmaceuticals, Inc., Eli Lilly and Company, Kyowa Kirin International plc, Pfizer, Inc., Acerus Pharmaceuticals Corporation, and Perrigo Company plc.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/2024

In the developing Markets of the Asia-Pacific, the Middle East, China, India, Japan and Australia, increased development prospects are to be expected due to the enormous potential in the individual countries. The various industry trends and threat factors are carefully examined and described in detail in this Testosterone Replacement Therapy report.

The study will also highlight the industrys key players, their product, business portfolio, Market share, financial status, regional share, segment sales, SWOT analysis, key strategies including mergers and acquisitions, product developments, joint ventures and partnerships, as well as improvements to their latest news.

In addition, this study will help our customers solve the following problems:

Cyclical Dynamics We forecast the dynamics of the industry through analytical and unconventional Market research approaches. Our customers use the information we provide to navigate Market uncertainty and disruption

Identifying Cannibalization Keys A major replacement for a product or service is the most common threat. Our customers can use our research findings to identify an important cannibalization of a Market. This helps them to prioritize their strategies for developing / delivering new products

Recognizing Emerging Trends Our range of ecosystems helps clients identify current Market trends. We also track possible impacts and disruptions that a Market would experience through a particular emerging trend. Our proactive analysis helps clients benefit from early intervention

Associated Opportunities With this report, customers can make decisions based on data, which increases the likelihood that the strategies in the real world will perform better, if not the best

For more information, see Download PDF Copy Here @ https://www.coherentmarketinsights.com/insight/request-pdf/2024

This study addresses some of the issues listed below:

How big is the Testosterone Replacement Therapy Market worldwide?

Which screen size is most preferred by consumers of Testosterone Replacement Therapy?

What type of distribution channel is most preferred by the producers of Testosterone Replacement Therapy?

What is the preferred age group for forwarding Testosterone Replacement Therapy to manufacturers?

What are the key factors that inhibit the growth of the Market, and to what extent are these factors affecting drivers and restraint systems?

How are the regulations affecting the growth of the Testosterone Replacement Therapy Market?

Which is the leading region / country for the growth of the Market? What is the expected growth rate of the leading regions in the forecasting period?

How will the emerging Testosterone Replacement Therapy Market develop in the coming years? How should the consumption pattern develop in the future?

Who are the main players in the global Testosterone Replacement Therapy Market? What is the current Market position of the key players? Who are the emerging players in this industry?

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Name: Mr. Raj Shah

Phone: US +12067016702 / UK +4402081334027

Email: [emailprotected]

Visit our Blog: https://hospitalhealthcareblog.wordpress.com/

Read the original:
Testosterone Replacement Therapy Market by application, Outlook and forecast 2019-2027 - Crypto Journal

Testosterone Replacement Therapy Market 2019 to 2024 With Top Countries Data : Opportunities, Industry Trends and Policies by Regions and Companies -…

Posted on by

The worldwide market for Testosterone Replacement Therapy is expected to grow at a CAGR of roughly -4.2% over the next five years, will reach 1410 million US$ in 2024, from 1820 million US$ in 2019, according to a new Reserach Report

Testosterone Replacement Therapy Market2019 Research report contains a qualified and in-depth examination of Testosterone Replacement Therapy Market. At first, the report provides the current Testosterone Replacement Therapy business situation along with a valid assessment of the Testosterone Replacement Therapy business. Testosterone Replacement Therapy report is partitioned based on driving Testosterone Replacement Therapy players, application and regions. The progressing Testosterone Replacement Therapy economic situations are additionally discovered in the report.

Short Description About Testosterone Replacement Therapy Market :

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.

Get Sample PDF of reporthttps://www.360researchreports.com/enquiry/request-sample/13836798

The research covers the current market size of the Testosterone Replacement Therapy market and its growth rates based on 5-year records with company outline ofKey players/manufacturers:

Scope Of The Report :

Testosterone deficiency, also referred to as hypogonadism, is a common problem among men aged between 40 and 79 years, with some studies stating that nearly 30% of all men worldwide are affected by hypogonadism. As the incidence of testosterone deficiency increases, it is expected that the demand for TRT will also show a simultaneous increase.The global average price of testosterone replacement therapy is in the decreasing trend, from 45.4 USD/Unit in 2012 to 34.9 USD/Unit in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.The classification of testosterone replacement therapy includes gels, injections, patches and other types, and the proportion of gels in 2016 is about 72%.Testosterone replacement therapy is widely sold in hospitals, clinics and other field. The most proportion of testosterone replacement therapy is sold in clinics, and the consumption proportion is about 43%.North America region is the largest supplier of testosterone replacement therapy, with a production market share nearly 86% in 2016. Europe is the second largest supplier of Testosterone Replacement Therapy, enjoying production market share nearly 9.9% in 2016.North America is the largest consumption place, with a consumption market share nearly 83% in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 12%. Market competition is intense. AbbVie, Endo International, Eli Lilly, Pfizer, Actavis (Allergan)Bayer, etc. are the leaders of the industry. The top five players together held about 80% of the market in the same year and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry. The worldwide market for Testosterone Replacement Therapy is expected to grow at a CAGR of roughly -4.2% over the next five years, will reach 1410 million US$ in 2024, from 1820 million US$ in 2019, according to a new research study.This report focuses on the Testosterone Replacement Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Inquire more and share questions if any before the purchase on this report at https://www.360researchreports.com/enquiry/pre-order-enquiry/13836798

Report further studies the Testosterone Replacement Therapy market development status and future trend across the world. Also, it splits Testosterone Replacement Therapy market by Type and by Applications to fully and deeply research and reveal market profile and prospects.

Major Classifications are as follows:

Major Applications are as follows:

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Testosterone Replacement Therapy in these regions, from 2014 to 2024, covering

The Testosterone Replacement Therapy market report provides answers to the following key questions:

Purchase this report (Price 3480 USD for a single-user license) https://www.360researchreports.com/purchase/13836798

Major Points from Table of Contents:

1 Market Overview1.1 Testosterone Replacement Therapy Introduction1.2 Market Analysis by Type1.3 Market Analysis by Applications1.4 Market Dynamics1.4.1 Market Opportunities1.4.2 Market Risk1.4.3 Market Driving Force

2.Manufacturers Profiles

2.4.1 Business Overview2.4.2 Testosterone Replacement Therapy Type and Applications2.4.2.1 Product A2.4.2.2 Product B

3.Global Testosterone Replacement Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Testosterone Replacement Therapy Sales and Market Share by Manufacturer (2017-2018)3.2 Global Testosterone Replacement Therapy Revenue and Market Share by Manufacturer (2017-2018)3.3 Market Concentration Rate3.3.1 Top 3 Testosterone Replacement Therapy Manufacturer Market Share in 20183.3.2 Top 6 Testosterone Replacement Therapy Manufacturer Market Share in 20183.4 Market Competition Trend

4 Global Testosterone Replacement Therapy Market Analysis by Regions

4.1 Global Testosterone Replacement Therapy Sales, Revenue and Market Share by Regions4.1.1 Global Testosterone Replacement Therapy Sales and Market Share by Regions (2014-2019)4.1.2 Global Testosterone Replacement Therapy Revenue and Market Share by Regions (2014-2019)4.2 North America Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)4.3 Europe Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)4.4 Asia-Pacific Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)4.6 South America Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)4.6 Middle East and Africa Testosterone Replacement Therapy Sales and Growth Rate (2014-2019)

6 Testosterone Replacement Therapy Market Forecast (2019-2024)6.1 Global Testosterone Replacement Therapy Sales, Revenue and Growth Rate (2019-2024)6.2 Testosterone Replacement Therapy Market Forecast by Regions (2019-2024)6.3 Testosterone Replacement Therapy Market Forecast by Type (2019-2024)6.3.1 Global Testosterone Replacement Therapy Sales Forecast by Type (2019-2024)6.3.2 Global Testosterone Replacement Therapy Market Share Forecast by Type (2019-2024)6.4 Testosterone Replacement Therapy Market Forecast by Application (2019-2024)6.4.1 Global Testosterone Replacement Therapy Sales Forecast by Application (2019-2024)6.4.2 Global Testosterone Replacement Therapy Market Share Forecast by Application (2019-2024)

6.Sales Channel, Distributors, Traders and Dealers6.1 Sales Channel6.1.1 Direct Marketing6.1.2 Indirect Marketing6.1.3 Marketing Channel Future Trend6.2 Distributors, Traders and Dealers

7. Research Findings and Conclusion

8. Appendix8.1 Methodology8.2 Data Source

Continued..

About Us:

360 Research Reports is the credible source for gaining the market reports that will provide you with the lead your business needs. At 360 Research Reports, our objective is providing a platform for many top-notch market research firms worldwide to publish their research reports, as well as helping the decision makers in finding most suitable market research solutions under one roof. Our aim is to provide the best solution that matches the exact customer requirements. This drives us to provide you with custom or syndicated research reports.

Contact Us:Name: Mr. Ajay MoreEmail: [emailprotected]Organization: 360 Research ReportsPhone: +44 20 3239 8187/ +14242530807

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Testosterone Replacement Therapy Market 2019 to 2024 With Top Countries Data : Opportunities, Industry Trends and Policies by Regions and Companies

See the article here:
Testosterone Replacement Therapy Market 2019 to 2024 With Top Countries Data : Opportunities, Industry Trends and Policies by Regions and Companies -...

Testosterone Therapy Causing Blood Clots And Health Concerns? – Video

Posted on by


Testosterone Therapy Causing Blood Clots And Health Concerns?
Recently the FDA began requiring warning labels on Testosterone Replacement Therapy (TRT) pharmaceutical products. Some recent studies indicate a potential risk for blood clots if you use testoster...

By: Alpha Male Medical Institute

Continue reading here:
Testosterone Therapy Causing Blood Clots And Health Concerns? - Video

Benefits of Testosterone for Women Renew Me Today

Posted on by

Benefits of Testosterone for Women: The Case for Testosterone Replacement in Aging Women

Television, the internet, and magazine ads all target men with products that address the drop in testosterone that occurs with age, but despite being classified as a male hormone, testosterone is also produced by women. While its true that men produce far more testosterone than women do, during the early reproductive years, women have 10 times more testosterone than estrogen within the body, leading experts to believe that its really testosterone loss that results in many of the symptoms women go through in midlife, such as low libido, fatigue, low muscle tone, weight gain, and loss of mental focus.1

Testosterone for women has become a hot button issue as women begin to realize that they too are at risk for deficiencies since testosterone levels drop with age in women as well. Around the world, testosterone therapy is being used to treat the symptoms of testosterone deficiency in both pre- and post-menopausal women as research continues to show that healthy testosterone levels are essential for the physical and mental health of both men and women.

Since the ovaries are responsible for producing both estrogen and testosterone, as the ovaries age, they produce less estrogen and testosterone.2 As women enter pre-menopause, testosterone production is reduced, and once women reach menopause, its common for them to produce less than half the testosterone they did previously. Every woman becomes at risk for testosterone deficiency as she ages, and women who go through a hysterectomy or oophorectomy have an even higher risk of dealing with low testosterone levels.

Women who begin experiencing a testosterone deficiency often notice many of the same symptoms men deal with as they deal with low T levels. Low levels of testosterone in women often lead to an increased risk of osteoporosis, since low T levels can leach away strength from the skeleton.3 Low levels can also lead to an increased risk of gaining weight since testosterone levels have been linked with fat mass in women in studies published in the American Journal of Epidemiology.4

A report published in the Journal of Womens Health even showed that testosterone deficiencies could be a risk factor for the development of heart disease in women.5 Since cardiovascular disease is the number one killer of postmenopausal women, this is an interesting hypothesis that underscores the importance of balanced hormones in women, including testosterone.

Both women and men may experience a wide variety of symptoms with low testosterone, such as fatigue, weight gain, low libido, and mental fogginess. Testosterone therapy has the potential to relieve these symptoms. Low libido is one of the most common complaints among aging women, and studies show that treating women with testosterone can significantly improve their sex drive.6

For women going through menopause, testosterone therapy often provides symptom relief. Studies show that testosterone therapy in menopausal women can relieve the symptoms of menopause, including urinary urgency, incontinence, vaginal dryness, and hot flashes.7 Testosterone therapy may also help protect against cardiovascular events, dilating blood vessels and increasing blood flow, as well as offering a reduced risk of Type 2 diabetes by lowering insulin resistance.8

While some buy into the myth that testosterone therapy may increase the risk of breast cancer, studies show that instead of increasing a womans risk for the disease, taking testosterone may actually help prevent breast cancer.9 Other benefits of testosterone women may experience include improve focus and mental clarity, reduced fatigue, reduced anxiety, improved bone density, and increases in lean muscle mass.

Women suffering from testosterone deficiency can benefit from choosing bio-identical hormone replacement therapy (BHRT). Since bio-identical hormones have the same molecular structure as the hormones a womans body naturally produces, hormones can be properly used and naturally metabolized and excreted by the body.

When compared to traditional hormone replacement therapy, BHRT offers a much lower risk of side effects. BHRT is tailor made to meet each womans specific needs, ensuring that hormone levels are increased safely to prevent negative side effects.

Women who are aging or who have undergone a hysterectomy or oophorectomy are at risk for declining testosterone levels. Aging women who experience low libido, poor concentration, symptoms of menopause, or other symptoms related to low levels of testosterone can benefit from testosterone therapy.10 Choosing bio-identical hormone replacement therapy can benefit women by reducing the symptoms of menopause, preventing osteoporosis, protecting the heart, increasing lean muscle mass, and improving overall quality of life.11

For more information contact us at http://www.renewmetoday.com to take the hormone health test, and find out where your nearest office is.

References

See the rest here:
Benefits of Testosterone for Women Renew Me Today

Male Testosterone Replacement Therapy (TRT) | Laser Center of …

Posted on by

Feel Better with TRT and Get Back in the Game!

We hear a lot about the changes caused by menopause in women, but much less about andropause (so called manopause) or low testosterone in men. Young men in their late teens and twenties seem to have boundless energy driven by high testosterone levels, but that doesnt last. Testosterone levels drop about one percent a year after age 30 and many men experience an even steeper decline. This steady drop in testosterone can lead to a need for Testosterone Replacement Therapy (TRT).

Physical signs of declining testosterone (low T) include decreased muscle strength and size, increased fat- especially belly fat, loss of body hair, dry eyes, elevated blood pressure, thinning dry skin, enlarging fatty breasts (gynecomastia), and lack of body odor.

The Adam Questionaire is a sensitive tool for screening for low T. A decrease in sex drive or erectile dysfunction suggest low T. Other symptoms include decreased energy or strength, decreased enjoyment of life, sadness or grumpiness, falling asleep after dinner, or a recent deterioration in work performance.

Fortunately, most men can be restored to hormonal health with proper medical care. The benefits of testosterone replacement therapy (TRT) include increased energy and strength, increased muscle mass, decreased osteoporosis, improved cholesterol profile, lowered blood sugars, improved sexual function, and increased longevity.

Men experiencing the symptoms of low T need a focused medical history, physical exam, and laboratory testing by a physician with specialized training in TRT. Although testosterone may be replaced by transdermal gels or implanted pellets, most patients are best managed by self administered injections of bioidentical testosterone and HCG (human chorionic gonadotropin). Some men may also need estrogen blocking pills.

The good news is that many of these negative symptoms are not really from aging at all, but rather from low testosterone. You can improve your health and recapture the joy and vigor of life.

TRT is safe if appropriately prescribed and monitored. There is no evidence that testosterone causes cancer, however preexisting prostate cancer may grow faster with TRT. It is very important to have a prostate exam and a serum PSA (prostatic specific antigen) level prior to beginning therapy, and to monitor the PSA level regularly.

You may very well start feeling better within days. However, body composition changes will transform over several months as your testosterone (T) level is optimally tuned. Several patients have already reported weight loss and lean muscle gain within the first month. They have have also reported increased erection strength, better sex drive, and an overall uptick in energy.

Male breast enlargement (gynecomastia) is a sign of testosterone/estrogen imbalance. Patients with this problem may need an estrogen blocker in addition to TRT. Therapy does not reverse the enlargement, but often Laser Assisted Liposuction can correct it very nicely.

The Laser Center of Maryland proudly provides Baltimore, Annapolis, Columbia, Severna Park, Glen Burnie and Pasadena, Maryland with comprehensive and advanced laser surgery and cosmetic surgery.

Here is the original post:
Male Testosterone Replacement Therapy (TRT) | Laser Center of ...

Men’s T-Clinic: Testosterone Replacement: Dallas & Houston, TX

Posted on by

The founders of Mens T-Clinic, withseven convenient Texas locations Dallas, Frisco, The Colony, Houston, Cypress, Pearland, and Pasadena understand firsthand how devastating low testosterone can be. Founded by men afflicted with hypogonadism (commonly known as low testosterone, or Low T), the clinic has developed a thorough testosterone replacement therapy program for fast and effective relief. The founders established the Men's T-Clinic with three objectives in mind:

The Mens T-Clinic team understands the debilitating effects Low T can have on everyday life. For years, these men went untreated or were misdiagnosed and treated for symptoms instead of the underlying cause. After trying several different treatments and doctors, each found best results with regular therapy.

The outcomes for these men have been nothing short of phenomenal. All have seen an increase in physical and mental drive, better moods, increased libido, and a decrease in belly fat. Men's T-Clinic set out on a mission to improve men's health by establishing conveniently located clinics with no appointment necessary to provide therapy.

They offer multiple treatment options to suit the patient, not the drug companies. Treatment can range from injection therapy to pharmaceutical gels and creams. You can begin on your first visit, and therapy is covered by most insurance plans.

The motto at Mens T-Clinic is "Get back to being you."

Dr. Salvatore Campo directs the treatment plans at Men's T-Clinic. Dr. Campo has more than two decades of treating hypogonadism for men of all ages. If you suspect that you suffer from hypogonadism and want relief, call one of the Mens T-Clinics convenient locations or schedule an appointment online today.

Go here to read the rest:
Men's T-Clinic: Testosterone Replacement: Dallas & Houston, TX

Testim VS Androgel – Testosterone Replacement Therapy

Posted on by

The two major testosterone gel brands are Testim and Androgel. They are very similar and generally prescribed interchangeably, but sometimes insurance wont cover one or the other. Often, I hear that they wont cover Testim and people want to know if Androgel is just as good. So here is a general guide to choosing if you are lucky enough to have the choice which one is right for you.

Testim Vs Androgel I would try whichever your insurance covers first. If your insurance covers both medications, try whichever one has coupons or kickbacks. Ive heard people say they didnt pay any/much for Testim for the first year because the company (Auxilium) that markets the drug has a financial assistance program available for the first year.

Now that price and availability are out of the way, lets deal with smell: Testim smells. Some people think it smells good, and some cant stand it. Personally, I like it and my wife likes it. Ive found that women ask me what cologne Im wearing, and mention that they like it too. Still, if you or your wife dont like the smell of something you have to put on every day, that would be a deal-breaker. So try out a tube and see what you and, if applicable, your partner thinks about the Testim scent. Androgel doesnt have much of a smell at all.

Testim is sticky. Androgel goes on much like that hand-sanitizer stuff, while Testim seems to remain stickier longer. Some say this is why Testim seems to work better for them: Because it stays on the skin and soaks in better. These personal statements of efficacy cant be relied on as empirical data, however. But the fact that you can feel it on your skin longer, does bring up a question about Testim gel Vs Androgel: Does it take longer to soak in and, if so, does that increase the exposure time I have to worry about when it comes to my wife and children? The short answer is: NO. In-fact, according to US National Library of Medicines website, the wait-time for AndrogGel is much longer:

You should not shower, bathe, swim, or wash the place where you applied the medication for at least 2 hours after you apply Testim gel or at least 5-6 hours after you apply AndroGel .

Waste Testim comes in little single-use tubes so you go through more of them and it generates more waste. If you are eco-minded this may factor into your decision. Androgel comes in a dispenser with a little pump on it (like soap) so there is less waste.

But the real question when considering AndroGel Vs Testim is: Which works better? Which is the best? Which testosterone topical gel is going to get my testosterone levels on track fast, keep my levels steady, and keep me there for the long term since Ill be taking this stuff for many years to come? As you might guess, both brands have their fans. Personally, I like Testim. And here is a study to back up my personal preference:

Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Grober ED, Khera M, Soni SD, Espinoza MG, Lipshultz LI. Division of Urology, Mount Sinai Hospital and Womens College Hospital, University of Toronto, Toronto, ON, Canada. Summary of the study:

A change in testosterone gel preparation among initially unresponsive hypogonadal men is justified prior to abandoning or considering more invasive TRT. Changing from Androgel to Testim offers hypogonadal men the potential for improved clinical and biochemical responsiveness. Changing from Testim to Androgel is indicated to eliminate or minimize unwanted side effects.

Note: This study was done to find out if switching brands would help men who were unresponsive to one brand or the other.

More important to me than such a study is to find out from others who have been on TRT for more than a year, preferably several years or more, and hear about their experiences with both or either drug. Please comment below with your own experiences.

I am inclined toward a weekly injection over a daily application, but what does ones rear-end feel like after being used as a pin-cushion for decades? I dunno any bodybuilders out there want to elaborate on that?

See the article here:
Testim VS Androgel - Testosterone Replacement Therapy

Orchid | Testosterone Replacement

Posted on by

Testosterone is the male sex hormone. It is responsible for male sexual characteristics such as;

Having a unilateral orchidectomy (one testicle removed) should not affect the overall circulating testosterone level in the body, providing the remaining testicle is healthy and can produce enough testosterone to make up for any deficit. However in some men such as those who have had, or are having chemotherapy, testosterone production in the remaining testicle may be affected. This is usually not permanent but it may take quite a while after treatment for testosterone levels to recover.Alternatively, in men who have had a bilateral orchidectomy, the testosterone level will fall to a minimal level and in this situation men will need to start testosterone replacement therapy. After bilateral orchidectomy, the body will not be able to produce sperm and only very low levels of testosterone will be made from the adrenal glands.

If testosterone levels fall men may feel tired, low in mood and can develop hot flushes. Weight gain and a loss of muscle strength can also occur. These symptoms can often be quite vague and difficult to recognise.

Much more specifically, if the testosterone levels are much lower than normal, men usually notice a loss of or difficulty in achieving normal erections on waking up in the morning, a fall in sex drive (loss of libido)and difficulty in maintaining erections strong enough for masturbation or sexual intercourse.If testosterone levels are low for a prolonged time, breast swelling (gynaecomastia), thinning of the bones (osteoporosis) and increase the risk of cardiovascular disease.

Because treatment for testicular cancer is intense and occurs in a fairly short space of time, men not only have to recover from the physical and mental strain of their illness but may find themselves struggling with the symptoms of low testosterone as well. Although low mood and sometimes depression can occur after testicular cancer treatment, men should consider asking their specialist team or GP to check them for possible testosterone deficiency.A simple way of identifying potentially low testosterone levels is to have a blood test performed which can measure the level of testosterone that the body is producing.

It is important that this particular blood test is performed in the morning. Testosterone levels are at their highest early in the morning, and this is when the blood test can be performed accurately. The results should only take a few days to be fully processed in most areas.

A normal level of testosterone is usually considered to be between approximately 9 30 nmol/L (nanomoles per litre). A level below 8 nmol/L is considered to be low and the blood test should be repeated. If it is low on 2 occasions taken at the right time of the day, then men will usually benefit from starting testosterone replacement therapy.Borderline levels are between 9 12 nmol/L and will often be monitored however treatment is not usually started in this range as it does not make a difference to how most people feel. However if men are displaying symptoms of low testosterone with a borderline level a trial for 6- months can be commenced to see if it helps resolve the symptoms.

If a man is worried that they may have a low testosterone level, they should speak to their consultant and specialist team who can arrange for men to be assessed for this problem and see a hormone specialist (endocrinologist).

If men start any of these treatments their testosterone levels will have to be checked on a regular basis to ensure a normal level is achieved. Most people start to feel better within a few weeks of treatment, but it may take at least 3 months to obtain a steady level in the blood stream and to feel the full effects of treatment.If testosterone replacement therapy does improve a mans symptoms following treatment for testicular cancer then it can be continued indefinitely. In some men who have had a unilateral orchidectomy, testosterone levels may eventually return to normal and testosterone replacement therapy can be discontinued.

Some men may also find that it will take a little while to find the best treatment for them and may need to try different types of replacement therapy.

Although testosterone is commonly thought to cause aggression and hostility, it is more responsible for helping the body adapt to challenging and stressful events or situations.However like all medications testosterone replacement therapy may cause some side effects and it is important to read the information supplied with any medication.Common side effects are oily skin and spots. Less often, people complain of headaches, nausea, excess sweating, tiredness and mood changes.

Long term, doctors will need to perform safety monitoring to make sure that levels are within the normal range, and check that the testosterone has not affected the liver, blood count (circulating blood volume) or prostate gland.Testosterone does not cause prostate cancer but causes the prostate gland to enlarge. This means that testosterone treatment can increase the size of the prostate. However testosterone actively feeds prostate cancer and so treatment is not started in people who have active prostate cancer.

People at high risk of prostate cancer, or with a high prostate blood test (prostate specific antigen or PSA) may need to see a urologist to decide whether testosterone will be safe for them.Safety monitoring with blood tests and an examination of the prostate is also necessary for everyone over 40.It is extremely important that men do not take supplements of testosterone (such as those used in weight training, body building or available online) other than what has been medically prescribed. Too much testosterone can cause other medical problems.

Testosterone levels should be measured on a regular basis and the dose adjusted if needed to keep these normal.Men should not stop testosterone treatment without consulting their GP or specialist team.

To watch a video clip discussing Testosterone Replacement Therapy please click below.

Last reviewed 25/7/16 Next review January 2017

References available on request.

See more here:
Orchid | Testosterone Replacement

The LIFE*MOD Podcast With Dr. Gonzalez – Testosterone Replacement Therapy Part 2 – Video

Posted on by


The LIFE*MOD Podcast With Dr. Gonzalez - Testosterone Replacement Therapy Part 2
In this clip Dr. Gonzalez turns the tables and interviews Andrew about his experience being on Bio-Identical Testosterone. What changes has Andrew seen over ...

By: Life*Mod - premiere lifestyle modification

Read more here:
The LIFE*MOD Podcast With Dr. Gonzalez - Testosterone Replacement Therapy Part 2 - Video

testosterone replacement – Harvard Prostate Knowledge

Posted on by

An interview with Abraham Morgentaler, M.D.

It could be said that testosterone is what makes men, men. It gives them their characteristic deep voices, large muscles, and facial and body hair, distinguishing them from women. It stimulates the growth of the genitals at puberty, plays a role in sperm production, fuels libido, and contributes to normal erections. It also fosters the production of red blood cells, boosts mood, and aids cognition.

Over time, the testicular machinery that makes testosterone gradually becomes less effective, and testosterone levels start to fall, by about 1% a year, beginning in the 40s. As men get into their 50s, 60s, and beyond, they may start to have signs and symptoms of low testosterone such as lower sex drive and sense of vitality, erectile dysfunction, decreased energy, reduced muscle mass and bone density, and anemia. Taken together, these signs and symptoms are often called hypogonadism (hypo meaning low functioning and gonadism referring to the testicles). Researchers estimate that the condition affects anywhere from two to six million men in the United States. Yet it is an underdiagnosed problem, with only about 5% of those affected receiving treatment.

Studies have shown that testosterone-replacement therapy may offer a wide range of benefits for men with hypogonadism, including improved libido, mood, cognition, muscle mass, bone density, and red blood cell production. But little consensus exists on what constitutes low testosterone, when testosterone supplementation makes sense, or what risks patients face. Much of the current debate focuses on the long-held belief that testosterone may stimulate prostate cancer.

Dr. Abraham Morgentaler, an associate professor of surgery at Harvard Medical School and the director of Mens Health Boston, specializes in treating prostate diseases and male sexual and reproductive difficulties. He has developed particular expertise in treating low testosterone levels. In this interview, Dr. Morgentaler shares his views on current controversies, the treatment strategies he uses with his own patients, and why he thinks experts should reconsider the possible link between testosterone-replacement therapy and prostate cancer.

What signs and symptoms of low testosterone prompt the average man to see a doctor?

As a urologist, I tend to see men because they have sexual complaints. The primary hallmark of low testosterone is low sexual desire or libido, but another can be erectile dysfunction, and any man who complains of erectile dysfunction should get his testosterone level checked. Men may experience other symptoms, such as more difficulty achieving an orgasm, less-intense orgasms, a smaller amount of fluid from ejaculation, and a feeling of numbness in the penis when they see or experience something that would normally be arousing.

The more of these symptoms there are, the more likely it is that a man has low testosterone. Many physicians tend to dismiss these soft symptoms as a normal part of aging, but they are often treatable and reversible by normalizing testosterone levels.

Arent those the same symptoms that men have when theyre treated for benign prostatic hyperplasia, or BPH?

Not exactly. There are a number of drugs that may lessen sex drive, including the BPH drugs finasteride (Proscar) and dutasteride (Avodart). Those drugs can also decrease the amount of the ejaculatory fluid, no question. But a reduction in orgasm intensity usually does not go along with treatment for BPH. Erectile dysfunction does not usually go along with it either, though certainly if somebody has less sex drive or less interest, its more of a challenge to get a good erection.

Follow this link:
testosterone replacement - Harvard Prostate Knowledge

I’m Too EMBARRASSED to Start Testosterone Replacement Therapy… – Video

Posted on by


I #39;m Too EMBARRASSED to Start Testosterone Replacement Therapy...
To many guys reach out to me expressing insecurities about starting Testosterone Replacement Therapy due to fear of being judged. This video aims to empower men to make the best choice for...

By: bignoknow

Read the original:
I'm Too EMBARRASSED to Start Testosterone Replacement Therapy... - Video

testosterone replacement therapy clinics | Find a testosterone replacement therapy clinics – Video

Posted on by


testosterone replacement therapy clinics | Find a testosterone replacement therapy clinics
testosterone replacement therapy clinics | Find a testosterone replacement therapy clinics Testosterone Replacement Therapy -- The particular Insufficiency T...

By: testosterone replacement therapy clinics

See original here:
testosterone replacement therapy clinics | Find a testosterone replacement therapy clinics - Video

SEX On Testosterone Replacement Therapy: WILL I BECOME A BEAST? – Video

Posted on by


SEX On Testosterone Replacement Therapy: WILL I BECOME A BEAST?
Ask Noah #2: A subscriber of mine who is about to start his TRT wants to know if it will turn him into the Terminator in bedroom? His sex life has been non existent over the last couple years...

By: bignoknow

Originally posted here:
SEX On Testosterone Replacement Therapy: WILL I BECOME A BEAST? - Video

Viewer Mail – Testosterone Replacement Therapy/TRT Not Natty, Balls Busted, etc. – Video

Posted on by


Viewer Mail - Testosterone Replacement Therapy/TRT Not Natty, Balls Busted, etc.
Enter The Competition! https://www.youtube.com/watch?v=qFhPXPB2Hi4 list=UUnBtt1Hwi2FA6ucNKNVIHEg Enter The Competition! Viewer mail on TRT. Should I do more of these? Let me know. GO BLAZERS!...

By: It #39;s My Midlife Crisis

Read more:
Viewer Mail - Testosterone Replacement Therapy/TRT Not Natty, Balls Busted, etc. - Video

Jury Punishes AbbVie for False Advertising in First MDL Verdict – Legal Examiner

Posted on by

In June of 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed testosterone-replacement therapy (TRT) lawsuits into one court in the Northern District of Illinois. District Judge Matthew Kelley decided early on that trials would be scheduled based on the type of TRT product used. Since AbbVies product AndroGel leads the market in testosterone-replacement products, the first bellwether trials each involve AndroGel.

In the second case to be tried, a Chicago jury determined that manufacturer AbbVie should pay $150 million to an Oregon man who suffered a heart attack after taking the drug.

The plaintiff first started taking AndroGel in 2008, and used it through 2012. He suffered a heart attack that year, at 49 years old. He claimed that AbbVie failed to warn of the risks associated with their drug, which he claims include blood clots, heart attacks, and strokes. He also claimed that the company misled consumers when they aggressively advertised the drug as a solution for age-related low-T.

The jury came back with a split verdict. They awarded the plaintiff $150 in punitive damages, stating that AbbVie was liable for false marketing and fraudulent misrepresentation. At the same time, however, they concluded that the plaintiffs heart attack was not caused by AbbVies negligence, and did not award him any compensatory damages.

AbbVie blamed the plaintiffs heart attack on other risk factors, including high blood pressure and cholesterol, obesity, and smoking. The company is expected to appeal the verdict.

This is only the second of seven planned bellwether trials to go to a jury. (An earlier trial ended in a mistrial, and is expected to begin again in September.) The consolidated litigation includes about 4,000 lawsuits, with all plaintiffs claiming that the manufacturers failed to warn of cardiovascular and blood-clot-related risks.

Even if the verdict doesnt stand, it sends a powerful message to AbbVie, and shows that juries will likely react unfavorably to AbbVies aggressive million-dollar advertising campaign. The company marketed the drug as an effective treatment for low-T, which it described as a condition with the same symptoms of normal male aging, like fatigue, muscle loss, and drop in libido.

The FDA, however, approved testosterone replacement only for medically diagnosed low testosterone, or hypogonadism. Studies have shown that many of the men who were convinced to take the drug never had a single testosterone test to diagnose any medical condition.

In 2014, for example, researchers reported that 40.2 percent of U.S. men did not have a testosterone test in the 180 days before beginning therapy, and 50 percent had only one test (doctors usually conduct at least two to get an average reading).

Read the rest here:
Jury Punishes AbbVie for False Advertising in First MDL Verdict - Legal Examiner

Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market to Surpass US$ 99,772.2 Million by 2027 – CMI – Yahoo Finance

Posted on by

SEATTLE, April 23, 2020 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global human immunoglobulin (pH4) for intravenous injection (COVID-19) market is estimated to be valued at US$ 43,205.8 million in 2020, and is expected to exhibit a CAGR of 12.7% during the forecast period (2020-2027).

Key Trends:

Key trends in the market include viral disease outbreaks, the increasing prevalence of chronic lymphocytic leukemia, and demand for immune globulin products in the market.

According to the American Cancer Society around 60,530 new cases of leukemia will be diagnosed in the U.S in 2020 out of which 21,040 new cases will be of chronic lymphocytic leukemia (CLL).

Similarly, according to the Cancer Research UK, around 3,500 new cases of chronic lymphocytic leukemia (CLL) were diagnosed in the U.K in 2017.

Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/3790

Moreover, the growing demand for immune globulin (IG) products is expected to drive the human immunoglobulin (ph4) for intravenous injection (COVID-19) market growth. For instance, on August 12, 2019, the U.S. Food and Drug Administration (FDA) confirmed that demand for immune globulin products has increased in recent years and there is a shortage of Immune Globulin (Subcutaneous) (IGSC) and Immune Globulin (Intravenous) (IGIV) products in the U.S. The U.S. Food and Drug Administration is working closely with manufacturers such as Asceniv, Bivigam, Octagam, Panzyga, Privigen and others of various immune globulin (intravenous) (IGIV) products to help mitigate the supply situation for IG products.

Key Market Takeaways:

Key players operating in market are

Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Behring, Bayer AG, Grifols, S.A., Octapharma AG, Shanghai RAAS Blood Products Co., Ltd., Hualan Biological Engineering Inc., China Biologic Products, Inc., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Boya Bio-Pharmaceutical Group Co., Ltd., ADMA Biologics, Inc., and Sinopharm Group Co., Ltd.

Buy this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/3790

Market Segmentation:

Related Topics:

HEALTHCARE CONTRACT RESEARCH OUTSOURCING MARKET

Healthcare Contract Research Outsourcing is conducted by pharmaceutical and medical device sectors for development of new drugs and medical devices. Clinical trials form the key part of pharmaceutical drug and medical device development and in the current scenario clinical trials are conducted across multiple locations in various geographies. Increasing cost and time required for drug development is expected to propel growth of the global healthcare contract research outsourcing market over the forecast period.

Read more @ https://www.coherentmarketinsights.com/market-insight/healthcare-contract-research-outsourcing-market-3788

ANDROGEN REPLACEMENT THERAPY MARKET

Androgen replacement therapy (ART), often referred to as testosterone replacement therapy (TRT), is a form of hormone therapy, in which androgens, often testosterone, are replaced. ART is often prescribed to counter the effects of male hypogonadism. It typically involves the administration of testosterone through injections, skin creams, patches, gels, or subcutaneous pellets. Testosterone replacement therapy is a promising technology for improving symptoms of hypogonadism and to raise the testosterone level.

Read more @ https://www.coherentmarketinsights.com/market-insight/androgen-replacement-therapy-market-3787

Mr. ShahCoherent Market Insights1001 4th Ave. #3200 Seattle, WA 98154Tel: +1-206-701-6702Email: sales@coherentmarketinsights.com

Follow this link:
Global Human Immunoglobulin (pH4) for Intravenous Injection (COVID-19) Market to Surpass US$ 99,772.2 Million by 2027 - CMI - Yahoo Finance